PTBP1‐Mediated Alternative Splicing of DNAJB6 Promotes Everolimus Resistance in Clear Cell Renal Cell Carcinoma via EIF4B/PKIB/AKT/mTOR Positive Feedback Loop

Xiu‐wu Pan, Hong‐feng Zheng, Mu‐chen Li, Jia‐lin Zhou, Hang‐biao Zhang, Dong‐hao Lyu, Yi‐fan Tang, Tian‐yue Yang, Yi‐fan Liu, Zi‐chang Liu, Wen‐jie Ma, Yuan‐bo Zong · 2026

Read PTBP1‐Mediated Alternative Splicing of DNAJB6 Promotes Everolimus Resistance in Clear Cell Renal Cell Carcinoma via EIF4B/PKIB/AKT/mTOR Positive Feedback Loop by Xiu‐wu Pan, Hong‐feng Zheng, Mu‐chen Li, Jia‐lin Zhou, Hang‐biao Zhang, Dong‐hao Lyu, Yi‐fan Tang, Tian‐yue Yang, Yi‐fan Liu, Zi‐chang Liu, Wen‐jie Ma, Yuan‐bo Zong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13616274.txt.

Description

Xiu-wu Pan leads a large team tracing how kidney cancer cells learn to resist everolimus, a key drug for advanced clear cell kidney cancer, through a gene-cutting trick. The drug targets a growth pathway, yet tumours often escape. Single-cell gene readings linked a splicing controller, PTBP1, with both resistance and high pathway activity. Splicing is where a gene's message is edited before use, and PTBP1 steering it can favour a survival version of another gene.

Tests in patient tissue, animals, and dishes confirmed the chain: altered splicing of the DNAJB6 gene feeds a positive loop through partner proteins that switches the growth pathway back on. Cutting that loop could restore the drug's bite. For patients whose cancer has outgrown everolimus, the study names concrete points where a second drug might block the escape.

Catalog record

CREATORXiu‐wu Pan, Hong‐feng Zheng, Mu‐chen Li, Jia‐lin Zhou, Hang‐biao Zhang, Dong‐hao Lyu, Yi‐fan Tang, Tian‐yue Yang, Yi‐fan Liu, Zi‐chang Liu, Wen‐jie Ma, Yuan‐bo Zong
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13616274

Browse the full library · About the Tower of Babel